BUY INNOVATIONQ+

INNOVATION IGNITES THE WORLD…

and it all starts with an idea.

INNOVATION IGNITES THE WORLD…

and it all starts with an idea.

IP.COM combines intellectual property & patent intelligence software with comprehensive services which deliver competitive insights and powerful data analytics, enabling inventors, engineers, R&D teams, and IP professionals to make informed IP decisions.

Upcoming Webinar

Join us on April 25, 2023, for an inspiring webinar, “Women and Intellectual Property: Accelerating Innovation and Creativity”. Learn from these exceptional women’s achievements, insights, and perspectives and be part of the conversation on supporting women-led businesses. Don’t miss out!

PATENT SOLUTIONS

Get the insights and answers you need to reach the next stage of the innovation lifecycle. Our suite of products and services are designed for IP professionals, engineers, research and development teams, inventors and entrepreneurs, and more.

I can’t imagine being able to manage a large patent portfolio and to get the results we have enjoyed without features like semantic search and HD-Analyze in InnovationQ+. It’s like having a dedicated AI assistant.

Joe Maniko

Research Scientist, Kodak Alaris

PATENT SOLUTIONS

IQ Ideas Plus™ combines all the power of IQ Ideas™, IP.com’s market-leading brainstorming solution with Inventor’s Aide, a quick and accurate way to evaluate the quality of invention disclosures.

Our intellectual property search and analytics platform delivers solutions that cover the innovation lifecycle, from ideation to monetization.

Prior Art Database, the first and largest online prior art disclosure service, provides technical disclosures to patent offices around the world.

Patent & IP News
How Apple, the Largest Company in the World, Plays the Patent Infringement Gamble

How Apple, the Largest Company in the World, Plays the Patent Infringement Gamble

In recent news, Apple has faced a patent infringement suit regarding the blood oxygen technology in two of its Apple Watch Series models resulting in a halt in sales of their watch models. The halt in sales comes after the International Trade Commission ruled that these two models’ use of blood oxygen tracking violated a patent from health technology company Masimo.

read more